35.30
-0.24 (-0.68%)
| Penutupan Terdahulu | 35.54 |
| Buka | 35.54 |
| Jumlah Dagangan | 174,910 |
| Purata Dagangan (3B) | 402,870 |
| Modal Pasaran | 1,119,585,536 |
| Harga / Pendapatan (P/E TTM) | 33.30 |
| Harga / Pendapatan (P/E Ke hadapan) | 4.79 |
| Harga / Jualan (P/S) | 1.93 |
| Harga / Buku (P/B) | 4.65 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 6.61% |
| Margin Operasi (TTM) | 13.71% |
| EPS Cair (TTM) | 1.22 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 22.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -91.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 411.94% |
| Nisbah Semasa (MRQ) | 1.08 |
| Aliran Tunai Operasi (OCF TTM) | 198.44 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 341.32 M |
| Pulangan Atas Aset (ROA TTM) | 7.95% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Collegium Pharmaceutical, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 2.25 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.69% |
| % Dimiliki oleh Institusi | 117.12% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 48.00 (Truist Securities, 35.98%) | Beli |
| Median | 46.00 (30.31%) | |
| Rendah | 46.00 (Needham, 30.31%) | Beli |
| 46.00 (HC Wainwright & Co., 30.31%) | Beli | |
| Purata | 46.67 (32.21%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 38.91 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Nov 2025 | 46.00 (30.31%) | Beli | 40.66 |
| 11 Aug 2025 | 44.00 (24.65%) | Beli | 36.14 | |
| Truist Securities | 07 Nov 2025 | 48.00 (35.98%) | Beli | 40.66 |
| Needham | 28 Oct 2025 | 46.00 (30.31%) | Beli | 35.41 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance |
| 29 Oct 2025 | Pengumuman | Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment |
| 23 Oct 2025 | Pengumuman | Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 |
| 22 Oct 2025 | Pengumuman | Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences |
| 13 Oct 2025 | Pengumuman | Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing |
| 28 Aug 2025 | Pengumuman | Collegium to Participate in Upcoming Investor Conferences |
| 25 Aug 2025 | Pengumuman | Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |